FDA Clears Dexcom Real-Time APIs For Third-Party Apps And Devices
SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today U.S. Food and Drug Administration (FDA) clearance of the Dexcom Partner…